Utilization of Percutaneous Coronary Intervention During the COVID-19 Pandemic
Cardiovasc Revasc Med
.
2023 Jun:51:75-76.
doi: 10.1016/j.carrev.2023.01.029.
Epub 2023 Feb 7.
Authors
Joseph Heaton
1
,
Ndausung Udongwo
2
,
Anton Mararenko
2
,
Steve Imburgio
2
,
Anmol Johal
2
,
Sohrab Singh
3
,
Arif Asif
2
,
Brett Sealove
4
,
Jesus Almendral
4
,
Jeffrey Selan
4
Affiliations
1
Department of Medicine, Jersey Shore University Medical Center, Neptune City, NJ, United States of America. Electronic address:
[email protected]
.
2
Department of Medicine, Jersey Shore University Medical Center, Neptune City, NJ, United States of America.
3
Department of Internal Medicine, The Brooklyn Hospital Center, Brooklyn, NY, United States of America.
4
Department of Medicine, Division of Cardiology, Jersey Shore University Medical Center, Neptune City, NJ, United States of America.
PMID:
36804306
PMCID:
PMC9902339
DOI:
10.1016/j.carrev.2023.01.029
No abstract available
Keywords:
COVID-19; PCI; STEMI.
Publication types
Letter
MeSH terms
COVID-19*
Humans
Pandemics
Percutaneous Coronary Intervention* / adverse effects
SARS-CoV-2